loader2
Partner With Us NRI

Auro Laboratories Ltd share Price Today

Company details

176.20
179.50
75.12
307.20
6M Return 38.82%
1Y Return 123.94%
Mkt Cap.(Cr) 110.32
Volume 5,317
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 5,317
BSE

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Auro Laboratories Ltd shares SWOT Analysis

Strengths (7)

  • Rising Net Cash Flow and Cash from Operating activity
  • Company with high TTM EPS Growth
  • Strong Annual EPS Growth

Weakness (1)

  • Decline in Net Profit (QoQ)

Opportunity (2)

  • Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
  • Highest Recovery from 52 Week Low

Threats (3)

  • Companies with growing costs YoY for long term projects
  • Increasing Trend in Non-Core Income
  • RSI indicating price weakness
Discover More

Resistance and support

R1 178.9
R2 180.9
R3 182.2
Pivot

177.57

S1 175.6
S2 174.3
S3 172.3
EMA SMA
192.5
198.7
190.1
166.9
192.7
210.2
195.0
160.7
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
PADRONE MARKETING PVT LTD Bulk Purchase 2023-08-31 134.87 50000 BSE
AMIT DHANYAKUMAR CHORDIA Bulk Sell 2023-06-30 80.78 31240 BSE
AMIT DHANYAKUMAR CHORDIA Bulk Purchase 2023-05-18 97.64 50000 BSE
Discover More
Name Category Shares
SHARAT DEORAH PROMOTER 18.71%
SIDDHARTHA DEORAH PROMOTER 7.09%
SAMRIDHI DEORAH PROMOTER 3.87%
SHARAT DEORAH HUF PROMOTER 3.67%
AURO IMPEX PRIVATE LTD PROMOTER 18.75%

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Auro Laboratories Ltd Stocks COMPARISON

Financials( ₹ in Cr) Auro Laboratories Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 177.00 1,579.30 1,510.40 4,570.80 1,184.80
% Change -6.94 -1.20 -0.19 -1.43 0.39
Mcap ₹ Cr 110.32 378,926.98 121,944.71 121,340.57 119,218.60
Revenue TTM ₹ Cr 53.64 48,496.85 15,790.60 7,665.00 19,547.40
Net Profit TTM ₹ Cr 7.79 9,648.44 2,513.47 1,576.00 3,854.40
PE TTM 14.15 37.93 28.66 75.74 30.89
1 Year Return 123.94 51.13 48.56 25.57 103.71
ROCE 20.37 17.20 14.76 16.27 23.94
ROE 20.46 16.13 10.66 12.04 20.64
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 41.96 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 101,404.97 51,097.20
LAST 6M 186,293.66 40,305.54
LAST 12M 309,547.75 87,515.42

Auro Laboratories Ltd Information

Stock PE (TTM)
14.15
Promoter Holding
52.15%
Book Value
67.3451
ROCE
20.37%
ROE
20.46%
Description

  • Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company`s primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for API`s and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum. Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom. The Company received ISO 9001:2000 and WHO - cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.

Read More
Registered Address

K-56 MIDC Indl Area, Tarapur Boisar, Thane, Maharashtra, 401506

Tel : 91-22-66635456
Email : auro:aurolabs.com
Website : http://www.aurolabs.com
Registrar

Purva Sharegistry (I) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 530233
NSE Code :
Book Closure Date (Month) :
BSE Group : XT
ISIN : INE292C01011

FAQ’s on Auro Laboratories Ltd Shares

You can buy Auro Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Auro Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 16, 2024 04:01 PM the closing price of Auro Laboratories Ltd was Rs.177.00.

The latest PE ratio of Auro Laboratories Ltd as of Jul 16, 2024 04:01 PM is 14.15

The latest PB ratio of Auro Laboratories Ltd as of Jul 16, 2024 04:01 PM is 0.38

The 52-week high of Auro Laboratories Ltd share price is Rs. 307.20 while the 52-week low is Rs. 75.12

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 16, 2024 04:01 PM, the market cap of Auro Laboratories Ltd stood at Rs. 110.32 Cr.

Download App

Download Our App

Play Store App Store
market app